COVID-19, SARS-CoV-2, vaccination, booster, antibody, immunity
COVID-19, SARS-CoV-2, vaccination, fractional dose, half-dose, booster, BNT162b2
BNT162b2, Booster Vaccines, ChAdOx1-S, CoronaVac, COVID-19
pneumonia, hospitalisation, pneumococcal conjugate vaccine, children, Mongolia
Pneumococcal conjugate vaccine, infant vaccination schedules, pneumococcal carriage
pneumococcal vaccines, immunization schedules, herd immunity, pneumococcal carriage, immunogenicity, vaccine
pneumococcal conjugate vaccine, PCV13, vaccine-type carriage, indirect effects, Coverage, Papua New Guinea
Pneumococcal conjugate vaccine (PCV13), Pneumococcal carriage, Vaccine effectiveness, Indirect effects, Papua New Guinea